When there's no room to grow
Wednesday, July 9, 2008 - 12:07
in Mathematics & Economics
To maintain profits in the face of rising development costs and slow drug pipelines, big pharmaceutical firms are trying to cut back. Heidi Ledford examines how GlaxoSmithKline has tried to adapt.